Effect of routine mammography practice on tumour size of a registry-based series of breast cancer cases compared with those observed in a screening cohort

The British Journal of Radiology
L BucchiD Amadori

Abstract

Routine mammography (MX) practice based on self-referral is considered not to be susceptible to monitoring at the population level. Invasive breast cancer cases notified to the Romagna Cancer Registry between 1989 and 1991 (total 654) were stratified by MX experience and were compared for the proportion of lesions greater than 2 cm in size (T2+) with cases observed in the study group of the Swedish Two Counties Screening Trial (TCST). Any MX more than 6 months prior to diagnosis was considered a previous routine examination. The proportion of cases registered in Romagna within 6-11 months of the most recent MX was quite similar to that shown by the interval cases of the TCST (50% vs 53%). T2+ cases registered in Romagna 12-23 months (27%) and 24-35 months (19%) after previous MX were similar in frequency to those detected at second and later screens in the TCST (22%). For longer intervals, the percentage of large tumours in the Romagna series increased, up to 45% among the cases registered more than 48 months since last MX (p < 0.0001). The whole group of cases with previous MX in Romagna and its counterpart in the TCST (i.e. interval cases + cases detected at second and later screens) had the same size distribution (35% vs 34%...Continue Reading

References

Oct 1, 1992·Virus Research·P PuthavathanaC Y Kang
Nov 6, 1991·Journal of the National Cancer Institute·P M LantzP A Newcomb
Apr 1, 1991·American Journal of Public Health·J M LiffW D Flanders
Apr 18, 1990·Journal of the National Cancer Institute·A G Glass, R N Hoover
May 1, 1990·Cancer·D E Henson, L A Ries
Jan 1, 1993·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C La VecchiaF Parazzini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.